| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 46.3062 | 33 |
| GSM780708 | Untreated after 4 days (C2_1) | 41.7565 | 12 |
| GSM780709 | Untreated after 4 days (C3_1) | 48.5623 | 43 |
| GSM780719 | Untreated after 4 days (C1_2) | 47.2037 | 38 |
| GSM780720 | Untreated after 4 days (C2_2) | 43.7529 | 21 |
| GSM780721 | Untreated after 4 days (C3_2) | 44.4723 | 24 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 42.7845 | 16 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.3796 | 34 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 40.8195 | 9 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 39.0187 | 4 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 42.3727 | 15 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 46.5011 | 34 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 41.6863 | 12 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 35.853 | 1 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 42.4835 | 15 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 45.8487 | 31 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 47.409 | 39 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 42.3359 | 14 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 41.2907 | 10 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 41.4698 | 11 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 38.2428 | 3 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 43.7684 | 21 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 42.981 | 17 |